Owkin AI-Powered Cancer Testing Solutions Cleared in Europe

Rapid diagnostic solutions for breast and colorectal cancer from AI biotech Owkin have been granted approval for use across the pond, making them the first testing products to be cleared. The company, which has offices in Paris as well as New York City, will now offer these products to pathology labs, oncologists, and surgeons in the U.K., Germany, and France, with an eventual expansion to the U.S. on the cards...